ROUNDTABLE JSRM - The Way of Japan: Japan's Efforts to Promote Science and Industry in the Field of Regenerative Medicine
Saturday, June 3, 2023 09:00 AM - 10:00 AM
Room 242A
Roundtable
Background Materials
Moderator
Shin Kaneko, MD, PhD, CiRA, Kyoto University, Japan
Panelists
Atsushi Iwama, MD, PhD, Professor, University of Tokyo, Japan
Masahiro Kino-oka, PhD, Osaka University, Japan
Kiyoshi Okada, MD, PhD, Specially Appointed Professor, Osaka University, Japan
Session Description
The round table discussion promises to be a thought-provoking session with in-depth discussions on the latest advancements and challenges in the field of regenerative medicine from the Japanese perspective. Active participation from the audience is welcomed to engage in stimulating discussions and exchange of ideas. The session will be framed around two central topics:
Topic 1: Progress of Regenerative Medicine Research in Japan
- Current Status of Consideration for Regenerative Medicine in Japan - Kiyoshi Okada
- Research Advances in Manipulating Hematopoietic Cells in Japan - Atsushi Iwama
- Research Base for Cell Manufacturability in Osaka University - Masahiro Kino-oka
Moderator
Shin Kaneko, MD, PhD, CiRA, Kyoto University, Japan
Panelists
Atsushi Iwama, MD, PhD, Professor, University of Tokyo, Japan
Masahiro Kino-oka, PhD, Osaka University, Japan
Kiyoshi Okada, MD, PhD, Specially Appointed Professor, Osaka University, Japan
Session Description
The round table discussion promises to be a thought-provoking session with in-depth discussions on the latest advancements and challenges in the field of regenerative medicine from the Japanese perspective. Active participation from the audience is welcomed to engage in stimulating discussions and exchange of ideas. The session will be framed around two central topics:
Topic 1: Progress of Regenerative Medicine Research in Japan
- Manipulation of hematopoietic stem cells and bone marrow niche
- Automation and scaling-up for cell manufacturing
- Regulatory sciences for regenerative medicine in Japan
- New funding trends for regenerative medicine, cell therapy, and gene therapy in Japan
- Human resource development for cell processing operators in Japan
- Introduction of the regenerative medicine national consortium led by JSRM
